Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung

Critical Care Medicine

Volumn 32, Issue 10, 2004, Pages 2045-2049

  Yamada, Hiroshi ^a   Ishii, Ken J ^b   Klinman, Dennis M ^c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Bacterial DNA; CpG motif; Lung; Macrophage inflammatory protein 2; Tumor necrosis factor

Indexed keywords

BACTERIAL DNA; CYTOKINE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CHEMOTAXIS, LEUKOCYTE; CPG ISLANDS; DNA, BACTERIAL; LUNG; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MONOKINES; NEUTROPHILS; OLIGODEOXYRIBONUCLEOTIDES; PNEUMONIA; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5644227315     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142397.38134.EF     Document Type: Article

References (30)

1. Beutler B: Not "molecular patterns" but molecules. Immunity 2003; 19:155-156
2. Krieg AM, Yi AK, Matson S, et al: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-549
3. Klinman DM, Yi AK, Beaucage SL, et al: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Nat Acad Sci U S A 1996; 93:2879-2883
4. Beutler B, Hoebe K, Du X, et al: How we detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukoc Biol 2003; 74:479-485. Epub 2003 Jul 2001
5. Pisetsky DS: Immune activation by bacterial DNA: A new genetic code. Immunity 1996; 5:303-310
6. Hemmi H, Takeuchi O, Kawai T, et al: A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-745
7. Bauer S, Kirschning CJ, Hacker H, et al: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Nat Acad Sci U S A 2001; 98:9237-9242
8. Takeshita F, Leifer CA, Gursel I, et al: Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001; 167:3555-3558
9. Goldberg B, Urnovitz HB, Stricker RB: Beyond danger: Unmethylated CpG dinucleotides and the immunopathogenesis of disease. Immunol Lett 2000; 73:13-18
10. Sparwasser T, Miethke T, Lipford G, et al: Bacterial DNA causes septic shock. Nature 1997; 386:336-337
11. Sparwasser T, Miethke T, Lipford G, et al: Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997; 27:1671-1679
12. Deng GM, Nilsson IM, Verdrengh M, et al: Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999; 5:702-705
13. Deng GM, Liu ZQ, Tarkowski A: Intracisternally localized bacterial DNA containing cpg motifs induces meningitis. J Immunol 2001; 167:4616-4626
14. Gao JJ, Xue Q, Papasian CJ, et al: Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J Immunol 2001; 166:6855-6860
15. Gao JJ, Zuvanich EG, Xue Q, et al: Bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 1999; 163:4095-4099
16. Schwartz DA, Quinn TJ, Thorne PS, et al: CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 1997; 100:68-73
17. Scheule RK: The role of CpG motifs in immunostimulation and gene therapy. Adv Drug Deliv Rev 2000; 44:119-134
18. Yamada H, Gursel I, Takeshita F, et al: Effect of suppressive DNA on CpG-induced immune activation. J Immunol 2002; 169:5590-5594
19. Stunz LL, Lenert P, Peckham D, et al: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 2002; 32:1212-1222
20. Pisetsky DS, Reich CF: Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin Immunol 2000; 96:198-204
21. Zhu FG, Reich CF, Pisetsky DS: Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J Leukoc Biol 2002; 71:686-694
22. Krieg AM, Wu T, Weeratna R, et al: Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Nat Acad Sci U S A 1998; 95:12631-12636
23. Chen Y, Lenert P, Weeratna R, et al: Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 2001; 8:1024-1032
24. Gursel I, Gursel M, Yamada H, et al: Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 2003; 171:1393-1400
25. Takeshita S, Takeshita F, Haddad DE, et al: CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol 2000; 206:101-106
26. Tarkowski A, Wagner H: Arthritis and sepsis caused by Staphylococcus aureus: Can the tissue injury be reduced by modulating the host's immune system? Mol Med Today 1998; 4:15-18
27. Hudson LD, Milberg JA, Anardi D, et al: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301
28. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 2001; 16:83-96
29. Horn DL, Morrison DC, Opal SM, et al: What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin Infect Dis 2000; 31:851-858
30. Goldman G, Welbourn R, Kobzik L, et al: Reactive oxygen species and elastase mediate lung permeability after acid aspiration. J Appl Physiol 1992; 73:571-575